The Consortium groups are based in three of the leading UK universities. Prior to the formation of the Consortium each group had conducted at least one clinical trial for gene therapy. Therefore, our researchers have been at the forefront of this field for over 20 years.
The Consortium was formed in 2001 on the initiative of the then CF Trust Chief Executive Rosie Barnes. This timeline highlights some of our major achievements during this time including our two clinical trials.
As with any large organisation our biggest asset is our people and their skills, experience and expertise. Prior to the formation of the Consortium, each of the three sites had conducted at least one clinical trial for CF gene therapy. Today the Consortium is managed by our strategy group with representatives bringing together the required clinical, regulatory and scientific skills required to ensure that we meet our goals whilst still achieving optimal results.
Consortium FAQs. All you've ever wanted to know about the UK CFGTC.
The Consortium has signed the All Trials Petition an iniative aimed at encouraging the results of all clinical trials to be made public. The Campaign calls for action from governments, regulators and research bodies to implement measures to ensure trials past and present should be registered, and the full methods and the results reported.
Consortium Contact Details
The Consortium website and our social media accounts are maintained by our some of our Oxford team. The front end uses Twitter Bootstrap 3 giving a responsive layout accross a range of platforms and screen sizes. Sadly though we are aware that it doesn’t work very well on some versions of Internet Explorer.
We are seeking an enthusiastic Postdoctoral Research Assistant in gene therapy to work with the Gene Medicine Research Group, directed by Associate Professors Deborah Gill and Steve Hyde. The successful applicant will be keen to participate in translational research and have responsibility for investigating lentiviral gene delivery to the airways for expression of monoclonal antibodies, particularly broadly neutralising antibodies to protect against influenza. The project will involve the desig
We are seeking an enthusiastic Research Assistant in Gene Therapy to work with the Gene Medicine Research Group, directed by Associate Professors Deborah Gill and Stephen Hyde. As part of the UK Cystic Fibrosis Gene Therapy Consortium, we have developed a new lentiviral vector, which efficiently targets the airways. We have been awarded a Cystic Fibrosis Trust grant to aid preparation for a first-in-human clinical trial to investigate the feasibility of this viral gene therapy approach.